TIVC Key Statistics, Chart & Performance
The current stock price of TIVC is 0.84 USD. In the past month the price decreased by -33.96%. In the past year, price decreased by -76.59%.
TIVC Technical Analysis
TIVC Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TIVC. While TIVC has a great health rating, there are worries on its profitability.
TIVC Financial Highlights
Over the last trailing twelve months TIVC reported a non-GAAP Earnings per Share(EPS) of -9.87. The EPS increased by 88.87% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -120.5% | ||
| ROE | -134.25% | ||
| Debt/Equity | 0 |
TIVC Forecast & Estimates
TIVC Ownership
TIVC Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.01 | 188.146B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.1 | 169.625B | ||
| SYK | STRYKER CORP | 24.03 | 137.924B | ||
| BSX | BOSTON SCIENTIFIC CORP | 22.33 | 111.924B | ||
| BDX | BECTON DICKINSON AND CO | 13.75 | 59.33B | ||
| IDXX | IDEXX LABORATORIES INC | 43.67 | 51.339B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.26 | 46.291B | ||
| RMD | RESMED INC | 21.73 | 38.394B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.47 | 37.64B | ||
| DXCM | DEXCOM INC | 27.88 | 27.621B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TIVC
Company Profile
Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company is headquartered in Fremont, California and currently employs 7 full-time employees. The company went IPO on 2021-11-11. The Company’s biopharma program is focused on advancing its drug product candidate, Entolimod, into manufacturing, conducting process validation utilizing the output of such manufacturing with the intent of selling the biologic compounds either inside or outside the United States. The Company’s bioelectronic program is focused on developing non-invasive medical devices that influence biologic functions associated with various diseases and conditions. The company has an over-the-counter device, ClearUP, that treats sinus pain and pressure. The Company’s Toll-like Receptor 5 (TLR5) program’s lead product candidate is the late-stage TLR5 agonist, Entolimod, to treat acute radiation syndrome (ARS) and for remediating side effects of medical radiation and chemotherapy. The firm offers contract development and manufacturing organization through its subsidiary Velocity Bioworks, Inc.
Company Info
TIVIC HEALTH SYSTEMS INC
47685 Lakeview Blvd
Fremont CALIFORNIA US
Employees: 7
Phone: 18882766888
TIVIC HEALTH SYSTEMS INC / TIVC FAQ
What does TIVIC HEALTH SYSTEMS INC do?
Tivic Health Systems, Inc. operates as a bio-electronic health-tech company, which develops micro current therapy solutions for chronic diseases and conditions. The company is headquartered in Fremont, California and currently employs 7 full-time employees. The company went IPO on 2021-11-11. The Company’s biopharma program is focused on advancing its drug product candidate, Entolimod, into manufacturing, conducting process validation utilizing the output of such manufacturing with the intent of selling the biologic compounds either inside or outside the United States. The Company’s bioelectronic program is focused on developing non-invasive medical devices that influence biologic functions associated with various diseases and conditions. The company has an over-the-counter device, ClearUP, that treats sinus pain and pressure. The Company’s Toll-like Receptor 5 (TLR5) program’s lead product candidate is the late-stage TLR5 agonist, Entolimod, to treat acute radiation syndrome (ARS) and for remediating side effects of medical radiation and chemotherapy. The firm offers contract development and manufacturing organization through its subsidiary Velocity Bioworks, Inc.
What is the current price of TIVC stock?
The current stock price of TIVC is 0.84 USD. The price decreased by -11.58% in the last trading session.
Does TIVC stock pay dividends?
TIVC does not pay a dividend.
How is the ChartMill rating for TIVIC HEALTH SYSTEMS INC?
TIVC has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists TIVC stock?
TIVC stock is listed on the Nasdaq exchange.